Protalix Biotherapeutics, Inc. (PLX)
2.88
-0.13
(-4.32%)
USD |
NYAM |
Feb 27, 16:00
2.89
+0.01
(+0.35%)
After-Hours: 20:00
Protalix Biotherapeutics Cash from Investing (TTM) : -16.57M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Denali Therapeutics, Inc. | 255.28M |
| OraSure Technologies, Inc. | -6.81M |
| Nephros, Inc. | 0.00 |
| Agenus, Inc. | 0.393M |
| Curis, Inc. | -0.428M |